SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mkilloran who wrote (13195)8/13/1998 11:36:00 AM
From: DaiS  Read Replies (3) of 23519
 
FWIW, wizkidaces on yahoo, with an ID update of 12 August, claimed that the big news by end of August related to gene therapy announcement by Vivus - re experiments on rats. In fact he appeared not to understand too well about either gene therapy or muse and was corrected by another poster.

The information that I gave earlier on gene therapy was obtained from a still unpublished manuscript by Dr Christ. This was a photocopy of page proofs. Since interval between receipt by authors of page proofs and publications is usually short, 1-3 months, the paper itself could be coming out this or next month. It will be in one of the journals of the American Physiological Society, don't know which one.

No!! here is the abstract,
oac3.hsc.uth.tmc.edu

And the July issue of the journal
oac3.hsc.uth.tmc.edu
It must in August!?

So is Vivus going to make a splash with this. Remember how much that rat cancer cure made entremed go up.

Remember that here though, it is human cDNA that is used. If human DNA works in rats it will certainly be expected to work in humans.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext